医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

LONDON

An infectious disease, syphilis is relatively widespread. In the USA alone, for instance, about new 46,000 new cases were discovered in 2010. Syphilis is especially dangerous during pregnancy. It is a primary cause of over 505,000 stillbirth/neonatal deaths annually. The disease is hard to diagnose in its early stage. It can be discovered only by laboratory testing. However, the first test appeared only in the first decade of the 20^th century.

At present, the number of syphilis tests is fairly high and continues to grow given ongoing research activities of medical institutions. Country markets for syphilis diagnostics are characterized by the difference in test price schemes, consumer interests and priorities of health providers.

New market research report “Innovative Syphilis Diagnostic Technologies and Emerging Markets” developed by Venture Planning Group (VPG) offers a deep insight into the existing and emerging markets for syphilis diagnostics as well as an in-depth discussion of innovative syphilis diagnostics technologies. The study examines the syphilis diagnostics market in the USA, Europe (focusing on France, Germany, Italy, Spain and UK) and Japan. The report comprises comprehensive overview of the global market and diagnostic technologies. It delves into the market competition, alternative market penetration strategies, market entry barriers and risks. Valuable information on the market size and growth, sales volumes of leading suppliers, test volume, sales projections and market share estimates is provided for each country market studied in the research.

Report Details:

Title: Innovative Syphilis Diagnostic Technologies and Emerging Markets

Published: November, 2012

Pages: 231

Price: US$ 3,850.00

http://marketpublishers.com/report/life_sciences/diagnostics-diseases/innovative-syphilis-diagnostic-technologies-n-emerging-markets.html

More New Cutting-Edge Market Research Reports by VPG are Available:

• Innovative Hepatitis Diagnostic Technologies and Emerging Markets
• Innovative Herpes Diagnostic Technologies and Emerging Markets
• Innovative CMV Diagnostic Technologies and Emerging Markets
• Innovative Septicemia Diagnostic Technologies and Emerging Markets
• Innovative Shigella Diagnostic Technologies and Emerging Markets
• Innovative Streptococci Diagnostic Technologies and Emerging Markets

More new insightful market research studies by VPG can be found at http://marketpublishers.com/members/vpg/info.html